Research and Markets: Global Cell-Based Assay Market 2015-2019 – Increase in Adoption of Label-Free Cell-Based Assay
September 9, 2015 | By Business Wire News
DUBLIN
Research and Markets (http://www.researchandmarkets.com/research/qsb528/global_cellbased) has announced the addition of the “Global Cell-based Assay Market 2015-2019” report to their offering.
The global cell-based assay market to grow at a CAGR of 11.3% during 2014-2019.
The report includes the present scenario and the growth prospects of the global cell-based assay market for the period 2015-2019. Based on application, the market can be segmented into drug discovery and toxicology.
The report, Global Cell-based Assay Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
For analyzing a large amount of drug samples, automation is required during cell-based assays. This process involves analyzing around tens of thousands of samples per day. Robotic automation can be applied in drug screening with some modifications of cell-based assay system such as microplate lid handling and the use of automated incubators, laminar flow hoods, and biosafety cabinets. Many research laboratories and pharmaceutical companies are taking an increased interest in using automated cell-based assay techniques in drug discovery processes, which is expected to propel market growth during the forecast period.
According to the report, label-free cell-based assays analyze the target molecule without modifying it. As a result, these assays can screen complex targets. The assays are flexible for using various types of cells such as primary, mammalian, suspension, and adherent cells, propelling their adoption in the drug discovery segment. Label-free cell-based assays include GPCR, receptor panning, receptor tyrosine kinases, orphan receptor screening, and ion channels. Many consumers use these assays complementarily to the traditional assay technology.
Further, the report states that the lack technical expertise of medical professionals results in operational and technological issues, which hinders the adoption of these complex assays.
Key vendors
– EMD Millipore
– Perkin Elmer
– Sigma-Aldrich
– Life Technologies (a subsidiary of Thermo Fisher Scientific)
Other prominent vendors
– Agilent Technologies
– Attana
– BioTek Instruments
– BioVision
– BMG LABTECH
– Cayman Chemical
– Cisbio Bioassays
– Corning
– DiscoveRx
– F. Hoffmann-La Roche
– ProQinase
– XENOMETRIX
– Molecular Devices
– Pall Corporation
– Promega Corporation
For more information visit http://www.researchandmarkets.com/research/qsb528/global_cellbased
View source version on businesswire.com: http://www.businesswire.com/news/home/20150909006306/en/
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Chemicals
